Nandy Sneha, Wan Siu-Hin, Klarich Kyle
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Heart Views. 2020 Jan-Mar;21(1):49-51. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_92_18. Epub 2020 Jan 23.
The management of postprocedure severe aortic periprosthetic regurgitation after transcatheter aortic valve replacement (TAVR) is unknown. While valve-in-valve TAVR has been associated with favorable outcomes for degenerative surgically implanted bioprosthetic valves, there are no evidence-based guidelines for immediate TAVR valve in TAVR valve for periprosthetic regurgitation. We present a patient who underwent a TAVR valve in TAVR valve implantation within 48 h of her first procedure and showed a good response.
经导管主动脉瓣置换术(TAVR)后严重主动脉瓣周反流的处理尚不清楚。虽然瓣中瓣TAVR已被证明对退行性外科植入生物瓣膜有良好效果,但对于TAVR术后立即进行瓣中瓣TAVR治疗瓣周反流,尚无循证指南。我们报告了1例患者,在首次手术48小时内接受了TAVR瓣中瓣植入,效果良好。